Universitätsklinikum Freiburg

Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired Pneumonia: An Observational Study () Weckler BC, Pott H, Race A, Jugkaeo N, Karki K, Ringshandl S, Seidemann C, et al. Journal article Castleman’s disease in the rheumatological practice () Schmalzing M, Sander O, Seidl M, Marks R, Blank N, Kötter I, Tiemann M, et al. Journal article Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis () Hollenbach M, Heise C, Abou-Ali E, Gulla A, Auriemma F, Soares K, Leung G, et al. Journal article The application of a digital therapeutic reveals superior outcome compared to standard care in patients with anterior knee pain—a randomized controlled trial (2025) Ferner F, Schenke M, Lutter C, Petersen W, Efe T, Schmeling A, Izadpanah K, et al. Journal article AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment (2025) Lorenz NI, Sauer B, Urban H, Weinem JB, Parmar BS, Zeiner PS, Strecker MI, et al. Journal article Results of a multicenter, randomized trial examining a new transition model for post-kidney transplant adolescents (2025) Kreuzer M, Prüfe J, Dierks ML, Müther S, Bethe D, Büscher A, Heindl-Rusai K, et al. Journal article PAX3 expression patterns in ocular surface melanocytes (2025) Ulrich E, Kistenmacher S, Martin G, Schlötzer-Schrehardt U, Seitz B, Auw-Hädrich C, Schlunck G, et al. Journal article ACO/ARO/AIO-22 – External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group (2025) Dapper H, Fleischmann M, Tselis N, Diefenhardt M, Hofheinz RD, Weiß C, Grabenbauer GG, et al. Journal article Modeling a mesenchymal cell state by bioprinting for the molecular analysis of dormancy in melanoma (2025) Schmidt S, Fischer S, El Ahmad Z, Schmid R, Metzger E, Schüle R, Hellerbrand C, et al. Journal article Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study (2025) Decker T, Brucker C, Engel A, Fasching P, Göhler T, Jackisch C, Janssen J, et al. Journal article